This $1,188,750.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Trustees of Indiana University, doing business as Indiana University, to investigate the role of stromal cell factors in breast cancer progression. The project aims to elucidate how ancestry-dependent stromal cell characteristics influence breast cancer behavior and metastasis. This 3-year research initiative, with a planned completion date of January 30, 2028, will leverage Indiana University's expertise in biomedical sciences to advance the understanding of fundamental biological mechanisms underlying breast cancer. The findings from this grant-funded research have the potential to inform the development of new diagnostic tools and therapeutic strategies targeting the tumor microenvironment, ultimately improving outcomes for breast cancer patients.
Generated 3/4/25, 6:41 AM